<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Atossa Genetics Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Atossa Genetics Inc.

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Steven C. Quay, MD, PhD
    • FOUNDED
      2009
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Phio Pharmaceuticals Corp.

    Phio Pharmaceuticals Corp.

    Phio Pharmaceuticals is focused on developing the next generation of immuno-oncolo...

    Phio Pharmaceuticals is focused on developing t...

    Filing Type:    PU
    Ritter Pharmaceuticals, Inc.

    Ritter Pharmaceuticals, Inc.

    Ritter Pharmaceuticals, Inc. develops novel therapeutic products that modulate the...

    Ritter Pharmaceuticals, Inc. develops novel the...

    Filing Type:    PU
    Soliton, Inc

    Soliton, Inc

    Soliton, Inc. is a medical device company with a novel and proprietary platform te...

    Soliton, Inc. is a medical device company with ...

    Fundraising Status:    EC
    Filing Type:    RARD
    Ovid Therapeutics Inc.

    Ovid Therapeutics Inc.

    Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing...

    Ovid Therapeutics is a biopharmaceutical compan...

    Filing Type:    PU
    Lifevantage Corporation

    Lifevantage Corporation

    LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in Nutrigenomics - a new scien...

    LifeVantage Corporation (Nasdaq: LFVN) is a pio...

    Filing Type:    PU
    Global Blood Therapeutics, Inc.

    Global Blood Therapeutics, Inc.

    Global Blood Therapeutics, Inc. (GBT) is a clinical-stage biopharmaceutical dedica...

    Global Blood Therapeutics, Inc. (GBT) is a clin...

    Filing Type:    PU
    Odonate Therapeutics, Inc.

    Odonate Therapeutics, Inc.

    We are a pharmaceutical company dedicated to the development of best-in-class ther...

    We are a pharmaceutical company dedicated to th...

    Filing Type:    PU
    Oncolytics Biotech Inc.

    Oncolytics Biotech Inc.

    Oncolytics is focused on obtaining regulatory approval for pelareorep for metastat...

    Oncolytics is focused on obtaining regulatory a...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.